BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 820620 C[C@@H](C(=O)N1CC[C@H]([C@@H](C)C1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12)C(C)(C)C InChI=1S/C28H36FN3O3S/c1-18-16-32(27(33)19(2)28(3,4)5)14-13-23(18)25-17-31(6)26-12-9-21(15-24(25)26)30-36(34,35)22-10-7-20(29)8-11-22/h7-12,15,17-19,23,30H,13-14,16H2,1-6H3/t18-,19-,23+/m0/s1 PATOGJWQBSINFF-SFYKDHMMSA-N 411385 Preparation of 4-fluoro-N-(1-methyl-3-((3R,4R)-3-methyl-1-((R)-2,3,3-trimethylbutanoyl)piperidin-4-yl)-1H-indol-5-yl)benzenesulfonamide::US10385036, Example 1 Nuclear receptor ROR-gamma Human 8.20 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411385&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443233 406792901 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820621 C[C@H](C1CCCC1)C(=O)N1CC[C@H]([C@@H](C)C1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12 InChI=1S/C29H36FN3O3S/c1-19-17-33(29(34)20(2)21-6-4-5-7-21)15-14-25(19)27-18-32(3)28-13-10-23(16-26(27)28)31-37(35,36)24-11-8-22(30)9-12-24/h8-13,16,18-21,25,31H,4-7,14-15,17H2,1-3H3/t19-,20+,25+/m0/s1 WLLUSRQPEUSLOV-WZOHSFFVSA-N 411386 Preparation of N-(3-((3R,4R)-1-((R)-2-cyclopentylpropanoyl)-3-methylpiperidin-4-yl)-1-methyl-1H-indol-5-yl)-4-fluorobenzenesulfonamide::US10385036, Example 2 Nuclear receptor ROR-gamma Human 11.4 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411386&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443250 406792902 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820622 C[C@H]1CN(CC[C@H]1c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12)C(=O)C1CCCC1 InChI=1S/C27H32FN3O3S/c1-18-16-31(27(32)19-5-3-4-6-19)14-13-23(18)25-17-30(2)26-12-9-21(15-24(25)26)29-35(33,34)22-10-7-20(28)8-11-22/h7-12,15,17-19,23,29H,3-6,13-14,16H2,1-2H3/t18-,23+/m0/s1 LMLXETLMKQLISE-FDDCHVKYSA-N 411387 N-(3-((3R,4R)-1-(cyclopentanecarbonyl)-3- methylpiperidin-4-yl)-1-methyl-1H-indol-5-yl)- 4-fluorobenzenesulfonamide.::US10385036, Example 3 Nuclear receptor ROR-gamma Human 5.30 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411387&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443245 406792903 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820623 C[C@@H]1CN(CC[C@@H]1c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12)C(=O)C1CCCC1 InChI=1S/C27H32FN3O3S/c1-18-16-31(27(32)19-5-3-4-6-19)14-13-23(18)25-17-30(2)26-12-9-21(15-24(25)26)29-35(33,34)22-10-7-20(28)8-11-22/h7-12,15,17-19,23,29H,3-6,13-14,16H2,1-2H3/t18-,23+/m1/s1 LMLXETLMKQLISE-JPYJTQIMSA-N 411388 N-(3-((3S,4S)-1-(cyclopentanecarbonyl)-3- methyipipendin-4-yl)-1-methyl-1H-indol-5-yl)- 4-fluorobenzenesulfonamide.::US10385036, Example 4 Nuclear receptor ROR-gamma Human 33.8 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411388&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443239 406792904 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820624 CC(C)C(=O)N1CC[C@H]([C@@H](C)C1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12 InChI=1S/C25H30FN3O3S/c1-16(2)25(30)29-12-11-21(17(3)14-29)23-15-28(4)24-10-7-19(13-22(23)24)27-33(31,32)20-8-5-18(26)6-9-20/h5-10,13,15-17,21,27H,11-12,14H2,1-4H3/t17-,21+/m0/s1 PEMIKDFOTFZUSV-LAUBAEHRSA-N 411389 4-fluoro-N-(3-((3R,4R)-1-isobutyryl-3- methylpiperidin-4-yl)-1-methyl-1H-indol-5- yl)benzenesulfonamide.::US10385036, Example 5 Nuclear receptor ROR-gamma Human 5.10 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411389&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443232 406792905 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820625 Cn1cc(C2CCN(CC2)C(=O)c2ccns2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc12 InChI=1S/C24H23FN4O3S2/c1-28-15-21(16-9-12-29(13-10-16)24(30)23-8-11-26-33-23)20-14-18(4-7-22(20)28)27-34(31,32)19-5-2-17(25)3-6-19/h2-8,11,14-16,27H,9-10,12-13H2,1H3 ISULHBUWFIAJCN-UHFFFAOYSA-N 411390 Preparation of 4-fluoro-N-(3-(1-(isothiazole-5-carbonyl)piperidin-4-yl)-1-methyl-1H-indol-5-yl)benzenesulfonamide::US10385036, Example 6 Nuclear receptor ROR-gamma Human 75.9 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411390&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443214 406792906 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820626 C[C@H](C1CCCC1)C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12 InChI=1S/C28H34FN3O3S/c1-19(20-5-3-4-6-20)28(33)32-15-13-21(14-16-32)26-18-31(2)27-12-9-23(17-25(26)27)30-36(34,35)24-10-7-22(29)8-11-24/h7-12,17-21,30H,3-6,13-16H2,1-2H3/t19-/m1/s1 OLSBNAMMMCLIFR-LJQANCHMSA-N 411391 (R)-N-(3-(1-(2-cyclopentylpropanoyl)piperidin-4-yl)- 1-methyl-1H-indol-5-yl)-4- fluorobenzenesulfonamide::US10385036, Example 7 Nuclear receptor ROR-gamma Human 4.50 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411391&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443179 406792907 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820627 Cn1cc(C2CCN(CC2)C(=O)C2CC2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc12 InChI=1S/C24H26FN3O3S/c1-27-15-22(16-10-12-28(13-11-16)24(29)17-2-3-17)21-14-19(6-9-23(21)27)26-32(30,31)20-7-4-18(25)5-8-20/h4-9,14-17,26H,2-3,10-13H2,1H3 VXQXBIFZUKNPFO-UHFFFAOYSA-N 411392 N-(3-(1-(cyclopropanecarbonyl)piperidin-4-yl)-1- methyl-1H-indol-5-yl)-4-fluorobenzenesulfonamide. LC/MS [M + H]+: 456; Rt = 3.11 (method B)::US10385036, Example 8 Nuclear receptor ROR-gamma Human 17.1 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411392&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 135334832 406792908 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820628 CC(CC(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12)C(F)(F)F InChI=1S/C25H27F4N3O3S/c1-16(25(27,28)29)13-24(33)32-11-9-17(10-12-32)22-15-31(2)23-8-5-19(14-21(22)23)30-36(34,35)20-6-3-18(26)4-7-20/h3-8,14-17,30H,9-13H2,1-2H3 ROFWCJDZFLNSEX-UHFFFAOYSA-N 411393 4-fluoro-N-(1-methyl-3-(1-(4,4,4-trifluoro-3- methylbutanoyl)piperidin-4-yl)-1H-indol-5- yl)benzenesulfonamide::US10385036, Example 9 Nuclear receptor ROR-gamma Human 14.8 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411393&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 135334828 406792909 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820629 C[C@@H](C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12)C(C)(C)C InChI=1S/C27H34FN3O3S/c1-18(27(2,3)4)26(32)31-14-12-19(13-15-31)24-17-30(5)25-11-8-21(16-23(24)25)29-35(33,34)22-9-6-20(28)7-10-22/h6-11,16-19,29H,12-15H2,1-5H3/t18-/m0/s1 IYRWKVJEVQENMH-SFHVURJKSA-N 411394 (R)-4-fiuoro-N-(1-methyl-3-(1-(2,3,3- trimethylbutanoyl)piperidin-4-yl)-1H-indol-5- yl)benzenesulfonamide::US10385036, Example 10 Nuclear receptor ROR-gamma Human 5.60 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411394&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443180 406792910 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820630 Cn1cc(C2CCN(CC2)C(=O)C2CCC2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc12 InChI=1S/C25H28FN3O3S/c1-28-16-23(17-11-13-29(14-12-17)25(30)18-3-2-4-18)22-15-20(7-10-24(22)28)27-33(31,32)21-8-5-19(26)6-9-21/h5-10,15-18,27H,2-4,11-14H2,1H3 GQFMNCOIZWYQIC-UHFFFAOYSA-N 411395 N-(3-(1-(cyclobutanecarbonyl)piperidin-4-yl)-1- methyl-1H-indol-5-yl)-4-fluorobenzenesulfonamide::US10385036, Example 11 Nuclear receptor ROR-gamma Human 28.8 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411395&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443228 406792911 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820631 CC(C)CC(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12 InChI=1S/C25H30FN3O3S/c1-17(2)14-25(30)29-12-10-18(11-13-29)23-16-28(3)24-9-6-20(15-22(23)24)27-33(31,32)21-7-4-19(26)5-8-21/h4-9,15-18,27H,10-14H2,1-3H3 ZJRDZYYUVWYEJK-UHFFFAOYSA-N 411396 4-Fluoro-N-(1-methyl-3-(1-(3- methylbutanoyl)piperidin-4-yl)-1H-indol-5- yl)benzenesulfonamide::US10385036, Example 12 Nuclear receptor ROR-gamma Human 7.80 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411396&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443206 406792912 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820632 Cn1cc(C2CCN(CC2)C(=O)CC2CC2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc12 InChI=1S/C25H28FN3O3S/c1-28-16-23(18-10-12-29(13-11-18)25(30)14-17-2-3-17)22-15-20(6-9-24(22)28)27-33(31,32)21-7-4-19(26)5-8-21/h4-9,15-18,27H,2-3,10-14H2,1H3 QNNYGKCCTBETFG-UHFFFAOYSA-N 411397 N-(3-(1-(2-Cyclopropylacetyl)piperidin-4-yl)-1- methyl-1H-indol-5-yl)-4-fluorobenzenesulfonamide::US10385036, Example 13 Nuclear receptor ROR-gamma Human 16.9 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411397&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443248 406792913 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820633 Cn1cc(C2CCN(CC2)C(=O)C2CCCCC2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc12 InChI=1S/C27H32FN3O3S/c1-30-18-25(19-13-15-31(16-14-19)27(32)20-5-3-2-4-6-20)24-17-22(9-12-26(24)30)29-35(33,34)23-10-7-21(28)8-11-23/h7-12,17-20,29H,2-6,13-16H2,1H3 NIXBRWNECQAYBQ-UHFFFAOYSA-N 411398 N-(3-(1-(cyclohexanecarbonyl)-piperidin-4-yl)-1- methyl-1H-indol-5-yl)-4-fluorobenzenesulfonamide::US10385036, Example 14 Nuclear receptor ROR-gamma Human 5.60 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411398&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443236 406792914 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820634 Cc1cccc(F)c1C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12 InChI=1S/C28H27F2N3O3S/c1-18-4-3-5-25(30)27(18)28(34)33-14-12-19(13-15-33)24-17-32(2)26-11-8-21(16-23(24)26)31-37(35,36)22-9-6-20(29)7-10-22/h3-11,16-17,19,31H,12-15H2,1-2H3 DOECZHGXRKDQDH-UHFFFAOYSA-N 411399 4-fluoro-N-(3-(1-(2-fluoro-6- methylbenzoyl)piperidin-4-yl)-1-methyl-1H-indol-5- yl)benzenesulfonamide::US10385036, Example 15 Nuclear receptor ROR-gamma Human 6.80 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411399&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443237 406792915 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820635 CC(C)[C@H](C)C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12 InChI=1S/C26H32FN3O3S/c1-17(2)18(3)26(31)30-13-11-19(12-14-30)24-16-29(4)25-10-7-21(15-23(24)25)28-34(32,33)22-8-5-20(27)6-9-22/h5-10,15-19,28H,11-14H2,1-4H3/t18-/m0/s1 OONBVMHCJRJLDR-SFHVURJKSA-N 411400 (S)-N-(3-(1-(2,3-dimethylbutanoyl)pipendin-4-yl)-1- methyl-1H-indol-5-yl)-4-fluorobenzenesulfonamide::US10385036, Example 16 Nuclear receptor ROR-gamma Human 3.10 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411400&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443238 406792916 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820636 Cn1cc(C2CCN(CC2)C(=O)C2CCCC2)c2cc(NS(=O)(=O)c3ccccc3F)ccc12 InChI=1S/C26H30FN3O3S/c1-29-17-22(18-12-14-30(15-13-18)26(31)19-6-2-3-7-19)21-16-20(10-11-24(21)29)28-34(32,33)25-9-5-4-8-23(25)27/h4-5,8-11,16-19,28H,2-3,6-7,12-15H2,1H3 SULWDLLVDPQPFQ-UHFFFAOYSA-N 411401 N-(3-(1-(cyclopentanecarbonyl)piperidin-4-yl)-1- methyl-1H-indol-5-yl)-2-fluorobenzenesulfonamide::US10385036, Example 17 Nuclear receptor ROR-gamma Human 5.90 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411401&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139417771 406792917 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820637 CC(C)C(=O)N1CC[C@H](CC1(C)C)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12 InChI=1S/C26H32FN3O3S/c1-17(2)25(31)30-13-12-18(15-26(30,3)4)23-16-29(5)24-11-8-20(14-22(23)24)28-34(32,33)21-9-6-19(27)7-10-21/h6-11,14,16-18,28H,12-13,15H2,1-5H3/t18-/m1/s1 XRFOZCPJFWHAOT-GOSISDBHSA-N 411402 (R)-4-fluoro-N-(3-(1-isobutyryl-2,2-dimethylpiperidin-4-yl)-1-methyl-1H-indol-5-yl)benzenesulfonamide::US10385036, Example 18 Nuclear receptor ROR-gamma Human 7.00 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411402&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443217 406792918 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820638 Cn1cc([C@@H]2CCN(C(=O)C3CCCC3)C(C)(C)C2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc12 InChI=1S/C28H34FN3O3S/c1-28(2)17-20(14-15-32(28)27(33)19-6-4-5-7-19)25-18-31(3)26-13-10-22(16-24(25)26)30-36(34,35)23-11-8-21(29)9-12-23/h8-13,16,18-20,30H,4-7,14-15,17H2,1-3H3/t20-/m1/s1 PPOCSYDWYNGNDJ-HXUWFJFHSA-N 411403 (R)-N-(3-(1-(cyclopentanecarbonyl)-2,2-dimethylpiperdin-4-yl)-1-methyl-1H-indol-5H-yl)-4-fluorobenzenesulfonamide::US10385036, Example 19 Nuclear receptor ROR-gamma Human 3.70 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411403&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443251 406792919 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820639 C[C@H]1C[C@H](CCN1C(=O)C1CCCC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12 InChI=1S/C27H32FN3O3S/c1-18-15-20(13-14-31(18)27(32)19-5-3-4-6-19)25-17-30(2)26-12-9-22(16-24(25)26)29-35(33,34)23-10-7-21(28)8-11-23/h7-12,16-20,29H,3-6,13-15H2,1-2H3/t18-,20-/m0/s1 RHMSENQWNDPSQM-ICSRJNTNSA-N 411404 Preparation of N-(3-((2S,4S)-1-(cyclopentanecarbonyl)-2-methylpiperidin-4-yl)-1-methyl-1H-indol-5-yl)-4-fluorobenzenesulfonamide::US10385036, Example 20 Nuclear receptor ROR-gamma Human 91.3 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411404&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443247 406792920 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820640 C[C@H]1C[C@@H](CCN1C(=O)C1CCCC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12 InChI=1S/C27H32FN3O3S/c1-18-15-20(13-14-31(18)27(32)19-5-3-4-6-19)25-17-30(2)26-12-9-22(16-24(25)26)29-35(33,34)23-10-7-21(28)8-11-23/h7-12,16-20,29H,3-6,13-15H2,1-2H3/t18-,20+/m0/s1 RHMSENQWNDPSQM-AZUAARDMSA-N 411405 Preparation of N-(3-((2S,4R)-1-(cyclopentanecarbonyl)-2-methylpiperidin-4-yl)-1-methyl-1H-indol-5-yl)-4-fluorobenzenesulfonamide::US10385036, Example 21 Nuclear receptor ROR-gamma Human 9.00 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411405&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443183 406792921 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820641 COc1cc(ccc1F)S(=O)(=O)Nc1ccc2n(C)cc(C3CCN(CC3)C(=O)C(C)C)c2c1 InChI=1S/C25H30FN3O4S/c1-16(2)25(30)29-11-9-17(10-12-29)21-15-28(3)23-8-5-18(13-20(21)23)27-34(31,32)19-6-7-22(26)24(14-19)33-4/h5-8,13-17,27H,9-12H2,1-4H3 UBAWRLQVCCPNAU-UHFFFAOYSA-N 411406 Preparation of 4-fluoro-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-1H-indol-5-yl)-3-methoxybenzenesulfonamide::US10385036, Example 22 Nuclear receptor ROR-gamma Human 10.6 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411406&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443202 406792922 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820642 CC(C)C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)c(O)c3)cc12 InChI=1S/C24H28FN3O4S/c1-15(2)24(30)28-10-8-16(9-11-28)20-14-27(3)22-7-4-17(12-19(20)22)26-33(31,32)18-5-6-21(25)23(29)13-18/h4-7,12-16,26,29H,8-11H2,1-3H3 GTRWBZABUWRAQC-UHFFFAOYSA-N 411407 Preparation of 4-fluoro-3-hydroxy-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-1H-indol-5-yl)benzenesulfonamide::US10385036, Example 23 Nuclear receptor ROR-gamma Human 19.9 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411407&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139401503 406792923 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820643 CC(C)C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)c(O[C@@H]4CCOC4)c3)cc12 InChI=1S/C28H34FN3O5S/c1-18(2)28(33)32-11-8-19(9-12-32)24-16-31(3)26-7-4-20(14-23(24)26)30-38(34,35)22-5-6-25(29)27(15-22)37-21-10-13-36-17-21/h4-7,14-16,18-19,21,30H,8-13,17H2,1-3H3/t21-/m1/s1 ZLMLMGPVLKPLLR-OAQYLSRUSA-N 411408 Preparation of (R)-4-fluoro-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-1H-indol-5-yl)-3-((tetrahydrofuran-3-yl)oxy)benzenesulfonamide::US10385036, Example 24 Nuclear receptor ROR-gamma Human 5.70 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411408&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 135334739 406792924 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820644 C[C@@H](C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(C)cc3)cc12)C(C)(C)C InChI=1S/C28H37N3O3S/c1-19-7-10-23(11-8-19)35(33,34)29-22-9-12-26-24(17-22)25(18-30(26)6)21-13-15-31(16-14-21)27(32)20(2)28(3,4)5/h7-12,17-18,20-21,29H,13-16H2,1-6H3/t20-/m0/s1 YNZPSZQBBZOBFE-FQEVSTJZSA-N 411409 (R)-4-methyl-N-(1-methyl-3-(1-(2,3,3- trimethylbutanoyl)piperidin-4-yl)-1H-indol-5- yl)benzenesulfonamide::US10385036, Example 25 Nuclear receptor ROR-gamma Human 2.10 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411409&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443246 406792925 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820645 C[C@@H](C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3c(C)nn(C)c3C)cc12)C(C)(C)C InChI=1S/C27H39N5O3S/c1-17(27(4,5)6)26(33)32-13-11-20(12-14-32)23-16-30(7)24-10-9-21(15-22(23)24)29-36(34,35)25-18(2)28-31(8)19(25)3/h9-10,15-17,20,29H,11-14H2,1-8H3/t17-/m0/s1 ZMLXEXGCTBBMOL-KRWDZBQOSA-N 411410 (R)-1,3,5-trimethyl-N-(1-methyl-3-(1-(2,3,3- trimethylbutanoyl)piperidin-4-yl)-1H-indol-5-yl)-1H- pyrazole-4-sulfonamide::US10385036, Example 26 Nuclear receptor ROR-gamma Human 1.30 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411410&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 135334811 406792926 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820646 CCOc1ccccc1S(=O)(=O)Nc1ccc2n(C)cc(C3CCN(CC3)C(=O)[C@H](C)C(C)(C)C)c2c1 InChI=1S/C29H39N3O4S/c1-7-36-26-10-8-9-11-27(26)37(34,35)30-22-12-13-25-23(18-22)24(19-31(25)6)21-14-16-32(17-15-21)28(33)20(2)29(3,4)5/h8-13,18-21,30H,7,14-17H2,1-6H3/t20-/m0/s1 IJGFEKYRPKEHBF-FQEVSTJZSA-N 411411 (R)-2-ethoxy-N-(1-methyl-3-(1-(2,3,3- trimethylbutanoyl)piperidin-4-yl)-1H-indol-5- yl)benzenesulfonamide::US10385036, Example 27 Nuclear receptor ROR-gamma Human 1.70 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411411&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443255 406792927 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820647 C[C@@H](C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccccc3F)cc12)C(C)(C)C InChI=1S/C27H34FN3O3S/c1-18(27(2,3)4)26(32)31-14-12-19(13-15-31)22-17-30(5)24-11-10-20(16-21(22)24)29-35(33,34)25-9-7-6-8-23(25)28/h6-11,16-19,29H,12-15H2,1-5H3/t18-/m0/s1 ONHFNBQRKYJZQS-SFHVURJKSA-N 411412 (R)-2-fluoro-N-(1-methyl-3-(1-(2,3,3- trimethylbutanoyl)piperidin-4-yl)-1H-indol-5- yl)benzenesulfonamide::US10385036, Example 28 Nuclear receptor ROR-gamma Human 1.000 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411412&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443252 406792928 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820648 C[C@@H](C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccccc3)cc12)C(C)(C)C InChI=1S/C27H35N3O3S/c1-19(27(2,3)4)26(31)30-15-13-20(14-16-30)24-18-29(5)25-12-11-21(17-23(24)25)28-34(32,33)22-9-7-6-8-10-22/h6-12,17-20,28H,13-16H2,1-5H3/t19-/m0/s1 MHJHORMANKZWRU-IBGZPJMESA-N 411413 (R)-N-(1-methyl-3-(1-(2,3,3- trimethylbutanoyl)piperidin-4-yl)-1H-indol-5- yl)benzenesulfonamide::US10385036, Example 29 Nuclear receptor ROR-gamma Human 8.70 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411413&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 135334837 406792929 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820649 C[C@@H](C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3c(C)noc3C)cc12)C(C)(C)C InChI=1S/C26H36N4O4S/c1-16(26(4,5)6)25(31)30-12-10-19(11-13-30)22-15-29(7)23-9-8-20(14-21(22)23)28-35(32,33)24-17(2)27-34-18(24)3/h8-9,14-16,19,28H,10-13H2,1-7H3/t16-/m0/s1 HMSGZGCRSJZDCE-INIZCTEOSA-N 411414 (R)-3,5-dimethyl-N-(1-methyl-3-(1-(2,3,3- trimethylbutanoyl)piperidin-4-yl)-1H-indol-5- yl)isoxazole-4-sulfonamide::US10385036, Example 30 Nuclear receptor ROR-gamma Human 10.00 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411414&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 139417772 406792930 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820650 C[C@@H](C(=O)N1CCC(CC1)c1cn(C)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc12)C12CC(C1)C2 InChI=1S/C28H32FN3O3S/c1-18(28-14-19(15-28)16-28)27(33)32-11-9-20(10-12-32)25-17-31(2)26-8-5-22(13-24(25)26)30-36(34,35)23-6-3-21(29)4-7-23/h3-8,13,17-20,30H,9-12,14-16H2,1-2H3/t18-,19?,28?/m0/s1 NGLYKTLRUQUDMX-VURWPYGMSA-N 411415 (R)-N-(3-(1-(2-(bicyclo[1.1.1]pentan-1- yl)propanoyl)piperidin-4-yl)-1-methyl-1H-indol-5-yl)- 4-fluorobenzenesulfonamide::US10385036, Example 31 Nuclear receptor ROR-gamma Human 2.40 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411415&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 135334833 406792931 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820651 C[C@H](C1CCCC1)C(=O)N1CC[C@H]([C@@H](C)C1)c1cn(C)c2ccc(NS(=O)(=O)c3c(C)nn(C)c3C)cc12 InChI=1S/C29H41N5O3S/c1-18-16-34(29(35)19(2)22-9-7-8-10-22)14-13-24(18)26-17-32(5)27-12-11-23(15-25(26)27)31-38(36,37)28-20(3)30-33(6)21(28)4/h11-12,15,17-19,22,24,31H,7-10,13-14,16H2,1-6H3/t18-,19+,24+/m0/s1 ATVPPPZPBOVXPJ-XLNZFTOWSA-N 411416 N-(3-((3R,4R)-1-((R)-2-cyclopentylpropanoyl)- 3-methylpiperidin-4-yl}-1-methyl-1H-indol-5- yl)-1,3,5-trimethyl-1H-pyrazole-4- sulfonamide::US10385036, Example 32 Nuclear receptor ROR-gamma Human 2.50 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411416&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443244 406792932 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820652 CCOc1ccccc1S(=O)(=O)Nc1ccc2n(C)cc([C@@H]3CCN(C[C@@H]3C)C(=O)[C@H](C)C3CCCC3)c2c1 InChI=1S/C31H41N3O4S/c1-5-38-29-12-8-9-13-30(29)39(36,37)32-24-14-15-28-26(18-24)27(20-33(28)4)25-16-17-34(19-21(25)2)31(35)22(3)23-10-6-7-11-23/h8-9,12-15,18,20-23,25,32H,5-7,10-11,16-17,19H2,1-4H3/t21-,22+,25+/m0/s1 UREXSBIPNNKYDO-SGIRGMQISA-N 411417 N-(3-((3R,4R)-1-((R)-2-cyclopentylpropanoyl)- 3-methylpiperidin-4-yl)-1-methyl-1H-indol-5- yl)-2-ethoxybenzenesulfonamide::US10385036, Example 33 Nuclear receptor ROR-gamma Human 1.10 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411417&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443176 406792933 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820653 C[C@H](C1CCCC1)C(=O)N1CC[C@H]([C@@H](C)C1)c1cn(C)c2ccc(NS(=O)(=O)c3ccccc3F)cc12 InChI=1S/C29H36FN3O3S/c1-19-17-33(29(34)20(2)21-8-4-5-9-21)15-14-23(19)25-18-32(3)27-13-12-22(16-24(25)27)31-37(35,36)28-11-7-6-10-26(28)30/h6-7,10-13,16,18-21,23,31H,4-5,8-9,14-15,17H2,1-3H3/t19-,20+,23+/m0/s1 BICQVDFIOOOJTB-MIZPHKNDSA-N 411418 N-(3-((3R,4R)-1-((R)-2-cyclopentylpropanoyl)- 3-methylpiperidin-4-yl)-1-methyl-1H-indol-5- yl)-2-fiuorobenzenesulfonamide::US10385036, Example 34 Nuclear receptor ROR-gamma Human 0.900 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411418&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 122443207 406792934 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8 820654 C[C@H](C1CCCC1)C(=O)N1CC[C@H]([C@@H](C)C1)c1cn(C)c2ccc(NS(=O)(=O)c3cc(C)ccc3F)cc12 InChI=1S/C30H38FN3O3S/c1-19-9-11-27(31)29(15-19)38(36,37)32-23-10-12-28-25(16-23)26(18-33(28)4)24-13-14-34(17-20(24)2)30(35)21(3)22-7-5-6-8-22/h9-12,15-16,18,20-22,24,32H,5-8,13-14,17H2,1-4H3/t20-,21+,24+/m0/s1 OJEDEHYGSWNHTG-YZUZCNPQSA-N 411419 N-(3-((3R,4R)-1-((R)-2-cyclopentylpropanoyl)- 3-methylpiperidin-4-yl)-1-methyl-1H-indol-5- yl)-2-fluoro-5-methylbenzenesulfonamide::US10385036, Example 35 Nuclear receptor ROR-gamma Human 1.000 US Patent 10.7270/Q24X5B40 aid1803771 US10385036 Schnute, ME; Flick, AC; Jones, P; Kaila, N; Mente, SR; Trzupek, JD; Vazquez, ML; Wennerstal, GM; Xing, L; Zamaratski, E; Zhang, L; Unwalla, RJ 8/20/2019 7/13/2020 Pfizer Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=411419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=738&target=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=411419&enzyme=Nuclear+receptor+ROR-gamma&column=ki&startPg=0&Increment=50&submit=Search 135334817 406792935 1 MDRAPQRQHRASRELLAAKKTHTSQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQRCNAAYSCTRQQNCPIDRTSRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLHAEVQKQLQQRQQQQQEPVVKTPPAGAQGADTLTYTLGLPDGQLPLGSSPDLPEASACPPGLLKASGSGPSYSNNLAKAGLNGASCHLEYSPERGKAEGRESFYSTGSQLTPDRCGLRFEEHRHPGLGELGQGPDSYGSPSFRSTPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSTETESPVGLSK 3B0W,3KYT,3L0J,3L0L,4NB6,4QM0,4S14,4WLB,4WPF,4WQP,4XT9,4YPQ,4ZJR,4ZJW,4ZOM,5APH,5APJ,5APK,5AYG,5EJV,5ETH,5G42,5G43,5G44,5G45,5G46,5K38,5K3L,5K3M,5K3N,5K6E,5K74,5LWP,5NI5,5NI7,5NI8,5NIB,5UFO,5UFR,5UHI,5W4R,5X8S,5X8U,5YP5,5YP6,5ZA1,6B30,6B31,6B33,6BN6,6BR2,6BR3,6CN5,6CVH,6E3E,6E3G,6ESN,6FGQ,6J3N,6NAD,6NWS,6NWT,6NWU,6O98,6P9F,6Q2W,6R7A,6R7J,6R7K,6SAL,6SLZ,6T4G,6T4I,6T4J,6T4K,6T4X,6T4Y,6T50,6TLM,6TLQ,6TLT,6U25,6VQF,6VSW,6W9H,6W9I,6XAE,6XFV,7E3M,7JH2,7JTM,7JYM,7KCO,7KQJ,7KXD,7KXE,7KXF,7LUK,7NEC,7NP5,7NP6,7OFI,7OFK,7QP4,7W3P,7W3Q,8GXP Nuclear receptor ROR-gamma RORG_HUMAN P51449 Q5SZR9 Q8N5V7 Q8NCY8